In their article in this issue, Olshansky and Carnes [Gerontology 2013;59:85–92] spell out in perhaps the most explicit terms yet a view which they have long espoused: that increases in longevity will inevitably slow down in decades to come, since the rate of biomedical progress that everyone agrees would be necessary to avoid such a slowdown is far too dramatic to be plausible. By doing so, they also betray more explicitly than ever before the flaws in their own logic. It is ironic that these flaws, unlike the work they critique, are actually quite closely analogous to the flaws in Zeno’s paradox. Since others are offering their own comments on other parts of the article, I shall restrict my remarks on the article to those passages which refer specifically to my own work, together with the conclusion.

1.
Olshansky SJ, Carnes BA: Zeno’s paradox of immortality. Gerontology, 2013;59:85–92.
2.
de Grey ADNJ: Mitochondrial gene therapy: an arena for the biomedical use of inteins. Trends Biotechnol 2000;18:394–399.
3.
de Grey ADNJ, Alvarez PJJ, Brady RO, Cuervo AM, Jerome WG, McCarty PL, Nixon RA, Rittmann BE, Sparrow JR: Medical bioremediation: prospects for the application of microbial catabolic diversity to aging and several major age-related diseases. Ageing Res Rev 2005;4:315–338.
4.
de Grey ADNJ, Campbell FC, Dokal I, Fairbairn LJ, Graham GJ, Jahoda CAB, Porter ACG: Total deletion of in vivo telomere elongation capacity: an ambitious but possibly ultimate cure for all age-related human cancers. Ann NY Acad Sci 2004;1019:147–170.
5.
de Grey ADNJ: Foreseeable pharmaceutical repair of age-related extracellular damage. Curr Drug Targets 2006;7:1469–1477.
6.
de Grey ADNJ, Ames BN, Andersen JK, Bartke A, Campisi J, Heward CB, McCarter RJM, Stock G: Time to talk SENS: critiquing the immutability of human aging. Ann NY Acad Sci 2002;959:452–462.
7.
de Grey ADNJ: A strategy for postponing aging indefinitely. Stud Health Technol Inform 2005;118:209–219.
8.
Rae MJ, Butler RN, Campisi J, de Grey ADNJ, Finch CE, Gough M, Martin GM, Vijg J, Perrott KM, Logan BJ: The demographic and biomedical case for late-life interventions in aging. Sci Transl Med 2010;2(40):40cm21.
9.
SENS Foundation Research Advisory Board statement of principles. http://www.sens.org/sens-research/advisory-board.
10.
de Grey ADNJ: Resistance to debate on how to postpone ageing is delaying progress and costing lives. EMBO Rep 2005;6:S49–S53.
11.
de Grey ADNJ: Extrapolaholics anonymous: why demographers’ rejections of a huge rise in cohort life expectancy in this century are overconfident. Ann NY Acad Sci 2006;1067:83–93.
12.
de Grey ADNJ: Escape velocity: why the prospect of extreme human life extension matters now. PLoS Biol 2004;2:723–726.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.